전환성장인자-베타 억제제(TGF-βinhibitor)의 각막열상 후 각막혼탁 억제 효과 = The Inhibitory Effect of TGF-βInhibitor on the Corneal Opacity After Corneal Laceration

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the effects of TGF-β inhibitor on the wound healing process after corneal laceration, and its inhibitory effect on corneal scar formation. Methods: Forty Lewis rats were randomly divided into one control and three experimental groups (groups I, II, and III). After partial-thickness vertical linear corneal incision, a diluted solution with 10, 25, and 50 μg of TGF-β inhibitor was instilled into each eye of groups I, II, and III respectively. Corneal haze was measured by using slit-lamp biomicroscopic examination. Using histopathologic examination, we compared the number of stromal keratocytes and the arrangement of regenerated collagen fibers. We also performed immunohistochemistry to confirm the differential expression of fibronectin and α-smooth muscle actin in each group. Results: Group III showed less corneal haze and more regular arrangement of regenerated collagen fibers than the other groups. The number of stromal keratocytes and immunoreactivity to fibronectin and α-smooth muscle actin decreased as the dose of TGF-β inhibitor increased. Conclusions: TGF-β inhibitor effectively reduced corneal haze during corneal healing processes after corneal laceration.

참고문헌 (Reference)

1 Fini ME, "Unique regulation of the matrix metalloproteinase, gelatinase B" 36 : 622-633, 1995

2 Ohji M, "Transforming growth factor- beta stimulates collagen and fibronectin synthesis by human corneal stromal fibroblasts in vitro" 12 : 703-709, 1993

3 Thompson NL, "Transforming growth factor beta-1 in acute myocardial infarction in rats" 1 : 91-99, 1988

4 Wahl SM, "Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure" 12 : 61-74, 1992

5 Mathers WD, "Theevolution of scarring following penetrating keratoplasty. in: The cornea: Transactions of the World congress on the Cornea III. v. Ⅱ. chap. 16" Raven Press 1988

6 Safianik B, "Serious corneoscleral complications after pterygium excision with mitomycin C" 86 : 357-358, 2002

7 Rieck P, "Recombinant human basic fibroblast growth factor (Rh-bFGF) in three different wound models in rabbits: corneal wound healing effect and pharmacology" 54 : 987-998, 1992

8 Garana RM, "Radial keratotomy. II. Role of the myofibroblast in corneal wound contraction" 33 : 3271-3282, 1992

9 Petroll WM, "Quantitative analysis of stress fiber orientation during corneal wound contraction" 104 : 353-363, 1993

10 Cordeiro MF, "Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome" 10 : 59-71, 2003

11 Moller-Pedersen T, "Neutralizing antibody to TGF-beta modulates stromal fibrosis but not regression of photoablative effect following PRK" 17 : 736-747, 1998

12 Shah M, "Neutralizing antibody to TFG-beta 1,2 reduces cutaneous scarring in adult rodents" 107 : 1137-1157, 1994

13 Kim TI, "Mitomycin C, ceramide, and 5-fluorouracil inhibit corneal haze and apoptosis after PRK" 25 : 55-60, 2006

14 Azar DT, "Matrix metalloproteinases are expressed during wound healing after excimer laser keratectomy" 15 : 18-24, 1996

15 Hayasaka S, "Late complications after pterygium excision with high dose mitomycin C instillation" 84 : 1081-1082, 2000

16 Fini ME, "Keratocyte and fibroblast phenotypes in the repairing cornea" 18 : 529-551, 1999

17 Ohno K, "Keratocyte activation and apoptosis in transplanted human corneas in a xenograft model" 43 : 1025-1031, 2002

18 Eckes B, "Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis" 21 : 415-429, 1999

19 Jester JV, "Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes" 15 : 505-516, 1996

20 Rochels R, "In vivo evidence for the chemotactic activity of cyclooxygenase- and lipoxygenase-dependent compounds using a corneal implantation technique" 16 : 194-197, 1984

21 Siriwardena D, "Human antitransforming growth factor beta (2) monoclonal antibody-a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study" 109 : 427-431, 2002

22 Cordeiro MF, "Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent" 40 : 2225-2234, 1999

23 Desmouliere A, "Heparin induces alpha-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts" 67 : 716-726, 1992

24 Davison PF, "Fluorescent dyes demonstrate the uniform expansion of the growing rabbit cornea" 26 : 1202-1209, 1985

25 Hayashi K, "Expression of transforming growth factor-beta in wound healing of vitamin A-deficient rat corneas" 30 : 239-247, 1989

26 Carones F, "Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy" 28 : 2088-2095, 2002

27 Mita T, "Effects of transforming growth factor beta on corneal epithelial and stromal cell function in a rat wound healing model after excimer laser keratectomy" 236 : 834-843, 1998

28 Grant MB, "Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis" 33 : 32962-3301, 1992

29 Tuft SJ, "Corneal repair following keratectomy. A comparison between conventional surgery and laser photoablation" 30 : 1769-1777, 1989

30 Goodman GL, "Corneal healing following laser refractive keratectomy" 107 : 1799-1803, 1989

31 Krachmer JH, "Cornea, 2nd ed" Elsevier & Mosby 115-146, 2005

32 Davison PF, "Connective tissue remodeling in corneal and scleral wounds" 27 : 1478-1484, 1986

33 Jain S, "Antioxidants reduce corneal light scattering after excimer keratectomy in rabbits" 17 : 160-165, 1995